Lixte Biotechnology's LB-100 to be Evaluated by the National Cancer Institute in a Clinical Study of LB-100's Ability to Enter Recurrent Glioblastoma Multiforme Brain Tumors EAST SETAUKET, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced the opening of a pharmacologic study of the ability of its lead clinical compound,...

Enlighten IT Consulting Signs Cooperative Research Agreement with West Point   LINTHICUM HEIGHTS, Md., Oct. 29, 2018 (GLOBE NEWSWIRE) -- MacAulay-Brown, Inc. (MacB), an Alion company, announced today that its subsidiary, Enlighten IT Consulting, LLC, (EITC), has signed a...

TriaSys Technologies enters into Cooperative Research and Development Agreement with the US Coast Guard Boston, March 30, 2018 (GLOBE NEWSWIRE) -- TriaSys Technologies, a leading provider of innovative signal processing solutions, has signed a Cooperative Research and Development Agreement...

Cempra Enters Into a CRADA With the NIAID and Expands the Phase 3 Solithromycin Clinical Trial in Urogenital Gonorrhea to Include Additional Female Patients and Adolescents CHAPEL HILL, N.C., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...